About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2022 revenue of more than $3 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

chemagic™ Technology

Revvity´s chemagic™ Technology helps scientists and clinicians achieve the pre-requisite high quality of nucleic acids required to meet the growing demand for genetic testing in the field of oncology.

chemagic™ automated nucleic acid purification has the unique ability to process small to large sample volumes and has been used for diverse applications including MLPA for cancer testing, long read sequencing for identification of structural variants or epigenetic defects, digital PCR from cfDNA-based liquid biopsies for personalized medicine and more.

With CE-IVD certified kits as well as customized kits to fit specific needs, chemagic™ solutions help achieve the flexibility and efficiency required for every workflow.